Fosun International's NAV Growth and Strategic Focus under Guo Guangchang's Leadership

Fosun International's Strategic Vision for Growth

On March 31, 2026, Guo Guangchang, the Chairman of Fosun International, spoke candidly during the company’s annual results presentation for 2025. He addressed the significant RMB23.4 billion impairment provision made by the company, clarifying that it was a necessary accounting measure and not indicative of operational difficulties. Guo described the move as akin to "repairing the roof on a sunny day," asserting that the decision reflects Fosun's commitment to navigating long-term growth and stability.

Guo emphasized that this impairment signifies a pivotal moment for Fosun, marking the beginning of a new development stage. His strategic focus lies in divesting low-profit assets and reallocating resources towards core businesses that show high growth potential. This strategic shift aims to lead the company into a more streamlined and sustainable future.

Throughout the presentation, Guo showcased the strong performance of Fosun's core businesses, highlighting their resilience in the face of market challenges. The pharmaceutical sector, in particular, continues to thrive as it successfully expands into international markets, with multiple products launched globally and new promising developments in the pipeline. Concurrently, the insurance segment has demonstrated robust growth both domestically and abroad, with Fosun Insurance Portugal notably extending its operations to Latin America and Africa. Domestic entities such as Fosun United Health Insurance and Pramerica Fosun Life Insurance also reported considerable profit growth, reinforcing the sustainability of the company's income streams.

In the culture and tourism domain, Club Med achieved record results, showcasing the diversity and strength of Fosun's portfolio. Guo firmly believes that these businesses generate robust and sustainable profit and cash flow, forming the foundation for the company’s future expansion.

Guo asserted that with the completion of this significant provision, Fosun's future operating results will better reflect the quality and strength of its core segments. He expressed confidence in Fosun's capacity to weather economic cycles, reassuring stakeholders that while short-term challenges may arise, strategic changes will position the company for consistent, long-term growth.

Fosun International's recently adjusted net asset value (NAV) stands at RMB133.5 billion, resulting in a NAV per share of HKD18.1. In a display of commitment to shareholder interests, the company's Board of Directors announced a share buyback program. Both major shareholders and the management team have indicated plans to increase their stake in the company’s shares. Guo mentioned that Fosun is keen to introduce additional measures to reward shareholders, including optimizing the dividend policy in accordance with improved operational results and cash flow.

The company's annual results reveal that Fosun's total revenue reached RMB173.43 billion for 2025, with an operating profit from industrial operations of RMB4 billion. Notably, the four core subsidiaries together contributed RMB128.2 billion, comprising 74% of the group's total revenue. Fosun Pharma, one of its flagship units, reported a net profit attributable to its shareholders of RMB3.371 billion, marking a 21.69% increase year-over-year, while Fosun Insurance Portugal achieved a net profit of EUR201 million, reflecting a 15.8% growth.

Despite the overall stability in results, Fosun recognized the necessity of a non-cash impairment across lesser-performing real estate projects and other non-core assets, resulting in a book loss of RMB23.4 billion. Notably, 55% of this impairment was related to real estate, stressing the company’s decision to refocus.

Guo Guangchang's commitment to steering Fosun towards a robust and sustainable future underscores the company’s long-term vision in an evolving marketplace. His strategic insights aim not only to stabilize current operations but also to explore fresh avenues for growth and shareholder value enhancement, setting a positive tone for the years to come.